Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1683 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Spectrum Pharmaceuticals Q4 Total Revenues Up

Spectrum Pharmaceuticals posted a net income attributable to stockholders of $10.18m, or $0.20 per diluted share, compared to net loss of $8.87m, or $0.28 per diluted share, for

Neuroges Launches Qutenza 8% Pain Relief Patch

Neuroges said that in November 2009, Qutenza was approved by the FDA for the management of neuropathic pain associated with PHN. Qutenza is the prescription-strength topical treatment for

MDRNA Enters Into Research Deal With Pfizer

The relationship is expected to focus on the evaluation of MDRNA’s proprietary di-alkylated amino acids (DiLA2) platform and UsiRNA constructs for RNA interference (RNAi). This marks MDRNA’s fourth

Celsis Expands Analytical Chemistry Capabilities

Celsis claimed that LC-MS/MS allows the analysts to separate, quantify and identify elements in complex mixtures. The testing method works by using HPLC to initially separate the compounds,